Moss falls on his sword at Aviva
Andrew Moss, the Chief Executive Officer of insurance giant Aviva, has taken the hint from disgruntled shareholders, and has quit the post with immediate effect.
Andrew Moss, the Chief Executive Officer of insurance giant Aviva, has taken the hint from disgruntled shareholders, and has quit the post with immediate effect.
The move, instigated by Moss, follows last week's Aviva annual general meeting which saw a majority of shareholders vote against the remuneration report, an act seen as a protest against Moss's pay rising while the share price moved equally rapidly in the opposite direction.
The board has asked Chairman Designate John McFarlane to become interim Executive Deputy Chairman with immediate effect and Executive Chairman from July 1st, pending the appointment of a new Chief Executive Officer. It is envisaged that the head-hunting process will take a number of months, at the conclusion of which McFarlane will revert to the role of non-executive Chairman.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Andrew Moss will leave the board shortly and a further announcement will be made to confirm the financial terms of his departure and date of leaving.
JH
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge